Nathaniel E. Clark, Ph.D.
Affiliations: | 2012 | Molecular & Cellular Biology | University of Massachusetts, Amherst, Amherst, MA |
Area:
Biochemistry, General Biophysics, Cell BiologyGoogle:
"Nathaniel Clark"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Scott C. Garman | grad student | 2012 | U Mass Amherst | |
| (Structure, function, and pharmacological chaperoning of human alpha-N-acetylgalactosaminidase.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Garman S, Guce AI, Clark NE, et al. (2013) The molecular basis of pharmacological chaperoning in human alpha-galactosidase Molecular Genetics and Metabolism. 108: S41-S42 |
| Garman S, Clark NE, Metcalf MC. (2013) Pharmacological chaperones for human alpha-N-acetylgalactosaminidase Molecular Genetics and Metabolism. 108: S41 |
| Clark NE, Metcalf MC, Best D, et al. (2012) Pharmacological chaperones for human α-N-acetylgalactosaminidase. Proceedings of the National Academy of Sciences of the United States of America. 109: 17400-5 |
| Rood KL, Clark NE, Stoddard PR, et al. (2012) Adaptor-dependent degradation of a cell-cycle regulator uses a unique substrate architecture. Structure (London, England : 1993). 20: 1223-32 |
| Guce AI, Clark NE, Rogich JJ, et al. (2011) The molecular basis of pharmacological chaperoning in human α-galactosidase. Chemistry & Biology. 18: 1521-6 |
| Tomasic IB, Metcalf MC, Guce AI, et al. (2010) Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases. The Journal of Biological Chemistry. 285: 21560-6 |
| Guce AI, Clark NE, Salgado EN, et al. (2010) Catalytic mechanism of human alpha-galactosidase. The Journal of Biological Chemistry. 285: 3625-32 |
| Clark NE, Garman SC. (2009) The 1.9 a structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases. Journal of Molecular Biology. 393: 435-47 |